Clinical Trial

A Post Market Surveillance on INFUSE Bone Graft

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 20, 2025 (before its estimated August 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study aims to evaluate the safety and effectiveness of INFUSE™ Bone Graft in the real-world setting in Korea.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2022-03-24; most recent amendment 2025-03-17.
Status change: Not Yet Recruiting → Recruiting 2022-09-07
Trial Details
NCT Number NCT05299762
Lead Sponsor Medtronic Spinal and Biologics
Conditions Intervertebral Disc Degeneration, Spinal Fusion, Lumbar Disc Disease
Enrollment 600 participants
Start Date 2022-08-10
Primary Completion 2025-08-31 (estimated)
Study Completion 2025-08-31 (estimated)
Updated on ClinicalTrials.gov 2025-03-20